Analysis on Education Status of Intellectual Property of TCM Universities and Colleges Based on Questionnaire Investigation / 中国中医药信息杂志

Objective To provide references for the education of intellectual property of TCM universities and colleges.Methods A questionnaire investigation were administered to the graduate students of traditional Chinese medicine from 5 domestic TCM universities and colleges, and data were collected and analyzed, with the addition of Internet information searching. The importance of intellectual property education for graduate students and the status in the end were analyzed.Results Some noticeable problems still exist in the graduate student education on intellectual property, like lack of curriculums, poor after-class practice, less special lectures, and so on.Conclusion In order to tackle these problems, and to make the education of graduate students of traditional Chinese medicine better, the corresponding cultivation mechanisms should be established; the main educational points should be definite; the secure system of laboratory should be improved.

Fuzzy Cluster Analysis of Compositae Involved in Effective Patent of TCM Extract Combination on Drug Properties / 中国药房

OBJECTIVE:To classify the drug properties of Compositae involved in effective patent of TCM extract combina-tion. METHODS:Property,flavor and the meridian tropism of TCM were used as the parameters;by computer analysis software, fuzzy cluster analysis was conducted from Compositae mostly involved in effective patent of TCM extract combination which ap-proved before Jan. 1st in 2015 and kept till May 30th in 2015. RESULTS & CONCLUSIONS:27 ingredients of Compositae were involved with the functions as protecting liver almost. They were classified into 5 categories. The first category included 10 ingredi-ents as Dendranthema morifolium which were cold,bitter to taste,and in the liver and lung meridian,and all of them contained flavonoids compounds;the second category included 3 ingredients as Gnaphalium affine of which flavonoids compounds were main medicinal components;the third category included 5 ingredients as Atractylodes lancea which could protect liver and contained vola-tile oil;the forth category included 4 ingredients as Tussilago farfara which showed anti-inflammatory and anti-tumor effect;the fifth category included 5 ingredients as Erigeron breviscapus which contained ingredients for cardiovascular disease. Those catego-ries were similar not only in property,flavor and the meridian tropism,but also in active ingredients and effects. The researchers should further research TCM of which pharmacologic action are not well understood,by means of make reference to known TCM in the same category,and make preparation to save time and enlarge medicinal resource.

Regional development of patents of traditional Chinese medicine compounds on basis of cluster analysis / 中国中药杂志

<p><b>OBJECTIVE</b>To study current regional development and optimization schemes of patents of traditional Chinese medicine compounds.</p><p><b>METHOD</b>Simple statistics and cluster analysis were adopted for calculating application quantity, maintenance quantity and quantity of scientific research papers related to patents of traditional Chinese medicine compounds in different regions. On that basis, cluster analysis was used for studying current development patents of traditional Chinese medicine compounds in different regions.</p><p><b>RESULT</b>The 34 regions, including Chinese mainland, Hong Kong, Macau and Taiwan, were divided into four groups by cluster analysis according to the difference in quantities of patents and research papers. The first and third region are better, the second region is medium, while the forth region is not ideal.</p><p><b>CONCLUSION</b>Different regions shall adopt suitable development schemes for the development of traditional Chinese medicine compounds according to their actual situations. Reasonable regional alliance is helpful for inter-regional win-win and co-flourishing.</p>

Cluster analysis on authorized patents of compound traditional Chinese medicines with different efficacy in 2010 / 中国中药杂志

<p><b>OBJECTIVE</b>To discuss the authorized patent of compound traditional Chinese medicines with different efficacy in 2010, in order to provide reference for R&D of relevant compounds and patent protection.</p><p><b>METHOD</b>Literatures for patents of compound traditional Chinese medicines were searched to screen relevant data and create a sample space. The samples were classified by hierarchical cluster procedures and iterative partitioning procedures using "authorized percentage" and "authorized time interval" as variable quantities. The comprehensive results generated by the two clustering methods were used to draw a conclusion.</p><p><b>RESULT</b>The samples were classified into four groups by clustering methods, each has significant difference in authorized patents' number and authorized time interval with others.</p><p><b>CONCLUSION</b>Among compounds showing therapeutic advantage of traditional Chinese medicines, patents with short authorization period and in less number can be given most attention for patent application. Those with longer authorization period and in less number can be given more attention. While those with shorter authorization period and in large number can also be given attention for information guidance for traditional Chinese medicine science and technology and commercialization of patent achievements.</p>

Analyses on positive influence of harmonous development of traditional Chinese medicine compounds' researchs and patent protection / 中国中药杂志

Current patent protection of traditional Chinese medicine (TCM) compounds is far from being satisfactory with increasing research and development achievements. As patent protection of traditional Chinese medicine compounds is closely related with many fields such as research and development of new TCM drugs, industrial development and TCM internationalization, the development of research and harmonious development of TCM compounds and their patent protection is bound to have a far-reaching influence on domestic and even international societies.

Brief history of pharmaceutical standard system in China / 中国中药杂志

Pharmaceutical standard system which belongs to an important part of national drug policies is an inevitable result of the development of pharmacy. There was a long standing of pharmaceutical standard system in China whose germination could be traced back to Qin and Han dynasties, and it had laid a solid foundation for the establishment and improvement of modern pharmaceutical standard system by continual accumulation from the past dynasties. Since the founding of new China, distinguished achievements had been obtained on pharmaceutical standardization working,and currently it is in a new developing stage. There was a brief description in this paper on the development history of pharmaceutical standard system in China.